BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aroor AR, Mummidi S, Lopez-Alvarenga JC, Das N, Habibi J, Jia G, Lastra G, Chandrasekar B, DeMarco VG. Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness. Cardiovasc Diabetol 2021;20:80. [PMID: 33882908 DOI: 10.1186/s12933-021-01270-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kagami K, Harada T, Ishii H, Obokata M. Key Phenotypes of Heart Failure with Preserved Ejection Fraction. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.06.001] [Reference Citation Analysis]
2 Mustafa NH, Jalil J, Zainalabidin S, Saleh MS, Asmadi AY, Kamisah Y. Molecular mechanisms of sacubitril/valsartan in cardiac remodeling. Front Pharmacol 2022;13:892460. [DOI: 10.3389/fphar.2022.892460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kario K, Williams B. Angiotensin receptor–neprilysin inhibitors for hypertension—hemodynamic effects and relevance to hypertensive heart disease. Hypertens Res. [DOI: 10.1038/s41440-022-00923-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Gorb YG, GI L.T.Malaya Therapy National Institute NAMSU, 2A, Liubovi Maloy Ave., Kharkiv 61039, Ukraine, Serik SA, Tkachenko OV, Ryabukha VV. Modern Approaches to Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus. Ukr ž med bìol sportu 2022;7:14-31. [DOI: 10.26693/jmbs07.01.014] [Reference Citation Analysis]
5 Benko J, Samoš M, Bolek T, Prídavková D, Jurica J, Péč MJ, Galajda P, Mokáň M, Zhao R. Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy. Journal of Diabetes Research 2022;2022:1-10. [DOI: 10.1155/2022/3366109] [Reference Citation Analysis]
6 Chi C, Liu Y, Xu Y, Xu D. Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:707162. [PMID: 34458336 DOI: 10.3389/fcvm.2021.707162] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]